Recombinant Cynomolgus CD7 Protein (ECD, His Tag), HPLC-verified

<strong>Recombinant Cynomolgus CD7 Protein (ECD, His Tag), HPLC-verified</strong>_x000D_ <strong>Catalog number:</strong> B2019102_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 17.78 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> Recombinant Cynomolgus CD7 Protein (ECD, His Tag), HPLC-verified_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Uckun FM, Chelstrom LM, Tuel-Ahlgren L, Dibirdik I, Irvin JD, Langlie MC, Myers DE. TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus Antimicrob Agents Chemother. 1998 Feb;42(2):383-8._x000D_ 2: Waurzyniak B, Schneider EA, Tumer N, Yanishevski Y, Gunther R, Chelstrom LM, Wendorf H, Myers DE, Irvin JD, Messinger Y, Ek O, Zeren T, Langlie MC, Evans WE, Uckun FM. In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxin Clin Cancer Res. 1997 Jun;3(6):881-90._x000D_ 3: van Oosterhout YV, van Emst JL, Bakker HH, Preijers FW, Schattenberg AV, Ruiter DJ, Evers S, Koopman JP, de Witte T. Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study Int J Pharm. 2001 Jun 19;221(1-2):175-86._x000D_ 4: Hagrman D, Goodisman J, Dabrowiak JC, Souid AK. Kinetic study on the reaction of cisplatin with metallothionein Drug Metab Dispos. 2003 Jul;31(7):916-23._x000D_ 5: Subrahmanyam G, Rudd CE, Schneider H. Association of T cell antigen CD7 with type II phosphatidylinositol-4 kinase, a key component in pathways of inositol phosphate turnover Eur J Immunol. 2003 Jan;33(1):46-52._x000D_ 6: Chassaigne H, Lobinski R. Characterization of horse kidney metallothionein isoforms by electrospray MS and reversed-phase HPLC-electrospray MS Analyst. 1998 Oct;123(10):2125-30._x000D_ 7: Choi S, Lee J, Kumar P, Lee KY, Lee SK. Single chain variable fragment CD7 antibody conjugated PLGA/HDAC inhibitor immuno-nanoparticles: developing human T cell-specific nano-technology for delivery of therapeutic drugs targeting latent HIV J Control Release. 2011 Nov 30;152 Suppl 1:e9-10._x000D_ 8: Wang Y, Hess D, Hunziker PE, Kägi JH. Separation and characterization of the metal-thiolate-cluster domains of recombinant sea urchin metallothionein Eur J Biochem. 1996 Nov 1;241(3):835-9._x000D_ 9: Mounicou S, Ouerdane L, L'Azou B, Passagne I, Ohayon-Courtès C, Szpunar J, Lobinski R. Identification of metallothionein subisoforms in HPLC using accurate mass and online sequencing by electrospray hybrid linear ion trap-orbital ion trap mass spectrometry Anal Chem. 2010 Aug 15;82(16):6947-57._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/3707924">10: Bernhard WR, Vasák M, Kägi JH. Cadmium binding and metal cluster formation in metallothionein: a differential modification study Biochemistry. 1986 Apr 22;25(8):1975-80. </a>_x000D_ _x000D_ <strong>Products Related to Recombinant Cynomolgus CD7 Protein (ECD, His Tag), HPLC-verified can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>